IP Library › Granted Patent US 12,594,007
Granted Patent B2
US 12,594,007 · App. 18/004,834 · Granted Apr 7, 2026

Energy transmitting device and system to monitor and treat tinnitus

Inventors: Peter Arndt (Höllviken, SE); Fredrik Westman (Staffanstrop, SE); Arash Golshenas (Malmö, SE); Ali Jehanfard (Bara, SE)
Assignee: Circius Pharma AB
A61B5/128A61F11/045A61N2/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,594,007
App. No.
18/004,834
Granted
Apr 7, 2026
Kind
B2
Abstract

Disclosed is an energy transmitting device for use in a system to monitor and treat tinnitus, comprising: a first unit that produces energy for treating said tinnitus; and a second unit that is arranged to secure and fasten said first unit against a skin of said patient, wherein, when in operation, said first unit produces said energy based on a suggested treatment for transmission to said patient through bone conductivity for treating said tinnitus.

Claims (50)

1 . An energy transmitting device for use in a system to monitor and treat tinnitus, comprising:

a first unit having a first portion and a second portion that is attached to the first portion to form a cavity; and

a second unit including an adapter having a first side and a second side;

wherein the first unit includes a vibrating means accommodated in the cavity and connected to a peripheral region of the second portion, via a flexible ring, for enabling vibration of the vibrating means, and wherein the vibrating means is arranged in a central region of the second portion;

wherein the second unit includes an adhesive material arranged to attach the first side of the adapter to the skin of the patient and thereby permitting the first unit to be attached to the skin of the patient by being arranged within the adapter;

wherein, when in use, the vibrating means of the first unit is arranged to be in direct contact, or indirect contact via the adhesive or adapter, with the skin of the patient; and

wherein, when in operation, the first unit produces energy based on a suggested treatment for transmission to the patient through bone conductivity for treating the tinnitus.

2 . An energy transmitting device according claim 1 , wherein the adapter is integrated into the adhesive material for securing the first unit with the adhesive material, and is a magnetic adapter that secures the first unit through magnetism.

3 . An energy transmitting device according claim 1 , wherein the adapter comprises a snap lock that locks the first unit within the adapter and enables removal of the first unit from the adapter after use.

4 . An energy transmitting device according claim 3 , wherein the second unit comprises:

an adhesive material that includes a first hole; and

an adapter, which includes a second hole, and is integrated into the adhesive material, for securing the first unit with the adhesive material;

wherein the snap lock is configured to receive the first unit and lock the first unit within the adapter; and

wherein the first and the second holes enable the first unit, in use, to be in contact with the skin of the patient.

5 . An energy transmitting device according claim 1 , wherein the adapter is integrated into the adhesive material for securing the first unit with the adhesive material and includes a lock that receives the first unit and locks the first unit within the adapter;

wherein the adhesive material includes a first side that is arranged to be in contact with the skin of the patient, and a second side that is integrated with the adapter and is in contact with the first unit;

wherein, when in operation, when the adhesive material is arranged to be in contact with the skin of the patient, the first unit produces the energy based on the suggested treatment, and the adhesive material is configured to transmit the energy from the first unit to the patient through bone conductivity for treating the tinnitus.

6 . An energy transmitting device according to claim 1 , wherein the adapter is made of a flexible material for transmission of vibrations from the vibrating means to the skin of the patient.

7 . An energy transmitting device according to claim 1 , wherein the first unit further comprises a first conductive plate, a second conductive plate, a battery unit, a printed circuit board device, and an energy transmitting unit that are accommodated in the cavity;

wherein the battery unit is accommodated between the first conductive plate and the second conductive plate, the printed circuit board device is coupled to the battery unit, and the energy transmitting unit is fastened to the vibrating means; and

wherein the printed circuit board device and the second conductive plate are adapted to form a ring shape for accommodating the energy transmitting unit therein.

8 . An energy transmitting device according to claim 1 , wherein a locking ring is interposed between the first portion and the second portion.

9 . An energy transmitting device according to claim 1 , further comprising a charging device that, in operation, charges the energy transmitting device;

wherein the first portion of the energy transmitting device is to be at least partially accommodated in an indentation on a surface of the charging device for receiving an electric charge.

10 . An energy transmitting device according to claim 1 , wherein the first unit includes at least one of a first magnet or a first magnetic plate; and

wherein the second unit includes a magnetic adapter that is integrated into the adhesive material for securing the first unit with the adhesive material;

wherein the magnetic adapter includes at least one of a second magnet or a second magnetic plate that enables magnetic attachment between the magnetic adapter and the first magnet or the first magnetic plate of the first unit;

wherein the adhesive material includes a first side that is arranged to be in contact with the skin of the patient, and a second side that is integrated with the magnetic adapter and is in contact with the first unit; and

wherein the magnetic adapter is arranged to transmit the energy based on the suggested treatment to the patient through bone conductivity for treating the tinnitus.

11 . An energy transmitting device according to claim 1 , wherein the first unit produces the energy that is selected from at least one of white noise, electrical energy, electromagnetic energy, or light energy.

12 . An energy transmitting device according to claim 11 , wherein the first unit comprises a white noise generator that produces the white noise; and

wherein the white noise ranges from 20 hertz (Hz) to 20,000 Hz.

13 . An energy transmitting device according to claim 11 , wherein the first unit comprises an electrostimulator that produces the electrical energy; and

wherein the electrical energy ranges from 45 microamperes (μA) to 100 μA.

14 . An energy transmitting device according to claim 11 , wherein the first unit comprises a neurostimulator that produces the electrical energy, or the electromagnetic energy; and

wherein the electrical energy ranges from 45 microamperes (μA) to 100 μA, or the electromagnetic energy ranges from 10 hertz (Hz) to 90 Hz.

15 . An energy transmitting device according to claim 11 , wherein the first unit comprises a laser emitting device that produces the light energy; and

wherein the light energy has a wavelength range from 600 nanometres (nm) to 1000 nm.

16 . An energy transmitting device according to claim 11 , wherein said first unit comprises:

a plurality of buttons that is pre-programmed with a plurality of suggested treatment operations to treat the tinnitus; and

a second processor that is configured to execute at least one of the suggested treatment operations when at least one button is actuated by the patient.

17 . A system to monitor and treat tinnitus, the system comprising:

a sensor unit that includes at least one sensor to monitor a health condition associated with an auditory dysfunction of a patient;

a first processor and a database to collect patient data associated with the health condition associated with the auditory dysfunction of the patient and to suggest the suggested treatment for the tinnitus to the patient based on the collected patient data; and

an energy transmitting device according to claim 1 .

18 . A system according to claim 17 , further comprising an interface configured for the patient to provide, to the system, subjective information pertaining to a health condition of the patient;

wherein the first processor suggests the suggested treatment for the tinnitus to the patient based on the subjective information.

19 . A system according to claim 17 , wherein the first processor predicts a change in the tinnitus that is about to happen in future based on the patient data, indicates to the patient about the change in the tinnitus that is about to happen and to the patient to handle the tinnitus in the future.

20 . A system according to claim 19 , wherein the system further comprises an interface that enables the patient to provide information about when the changes in the tinnitus occur and transmits the information to a cloud server for analyzing the information to suggest the treatment for the tinnitus.

21 . A system according to claim 17 , wherein the at least one sensor comprises at least one of: an accelerometer, a temperature sensor, a pulse sensor, a blood pressure sensor, and an oxygenation sensor.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2025
From: DUEARITY AB
To: CIRCIUS PHARMA AB
Reel/Frame 072475/0134 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2023
From: ARNDT, PETER; WESTMAN, FREDRIK; GOLSHENAS, ARASH; JEHANFARD, ALI
To: DUEARITY AB
Reel/Frame 062531/0363 →
Priority Claims (1)
SE 2030236-0 · Jul 27, 2020 · national
Continuity (1)
Related Publication 20230255514A1 · Aug 17, 2023
References Cited (14)
US 6358272B1 · Wilden · 2002 [cited by applicant]
US 10398897B2 · Owen et al. · 2019 [cited by applicant]
US 10512750B1 · Lewin Jessen et al. · 2019 [cited by applicant]
US 20080249594A1 · Dietrich et al. · 2008 [cited by applicant]
US 20180271710A1 · Boesen · 2018 [cited by examiner]
US 20180310107A1 · Westerkull · 2018 [cited by examiner]
US 20190014425A1 · Liao · 2019 [cited by examiner]
US 20190090044A1 · Boesen · 2019 [cited by examiner]
US 20190163952A1 · Mueller-Wehlau · 2019 [cited by examiner]
US 20200001085A1 · Owen et al. · 2020 [cited by applicant]
CN 106954155B · 2017 [cited by applicant]
WO 2012168543A1 · 2012 [cited by applicant]
WO 2019038746A1 · 2019 [cited by applicant]
WO 2019157443A1 · 2019 [cited by applicant]